The enduring success of sildenafil has undeniably transformed the drug landscape. However, investing in companies heavily reliant on biosimilars and the waning patent rights surrounding this iconic https://bookmarkshq.com/story23220073/sildenafil-and-drugmakers-a-uncertain-opportunity